{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:17:59Z","timestamp":1699402679381},"reference-count":42,"publisher":"Radboud University","issue":"5","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TIJDSCHR. GERONTOLOGIE GER."],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s12439-011-0038-x","type":"journal-article","created":{"date-parts":[[2011,12,2]],"date-time":"2011-12-02T14:13:02Z","timestamp":1322835182000},"page":"226-232","source":"Crossref","is-referenced-by-count":0,"title":["Leverlijden bij oudere personen"],"prefix":"10.54195","volume":"42","author":[{"given":"T.","family":"Ghillemijn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Laleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Flamaing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"14109","published-online":{"date-parts":[[2011,12,2]]},"reference":[{"key":"38_CR1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.278.5337.419","volume":"278","author":"S Lamberts","year":"1997","unstructured":"Lamberts S, van den Beld A, van der Lely A-J. The endocrinology of aging. Science 1997; 278: 419\u2013424.","journal-title":"Science"},{"key":"38_CR2","unstructured":"Popper H. Aging and the liver. In: Popper H, Schaffner F, et al. Progress in liver disease, volume VIII, 1986: 659\u201383."},{"key":"38_CR3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0168-8278(01)00142-8","volume":"35","author":"M Parola","year":"2001","unstructured":"Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. Journal of hepatology 2001; 35: 297\u2013306.","journal-title":"Journal of hepatology"},{"key":"38_CR4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/gerona\/55.11.B533","volume":"55","author":"K Takubo","year":"2000","unstructured":"Takubo K, Nakamuro K, Izumiyama N, et al. Telomere shortening with age in human liver. J Gerontol A Biol Sci Med Sci 2000; 55: 533\u2013536.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"38_CR5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.1840090222","volume":"9","author":"H Wynne","year":"1989","unstructured":"Wynne H, Cope L, Mutch E, et al. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 1989; 9: 297\u2013301.","journal-title":"Hepatology"},{"key":"38_CR6","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(02)08524-0","volume":"359","author":"DG Le Couteur","year":"2002","unstructured":"Le Couteur DG, Fraser R, Cogger V, McLean A. Hepatic pseudocapillarisation and atherosclerosis in ageing. The Lancet 2002; 359: 1612\u20131615.","journal-title":"The Lancet"},{"key":"38_CR7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0889-8553(05)70195-3","volume":"30","author":"A Regev","year":"2001","unstructured":"Regev A, Schiff E. Liver disease in the elderly. Gastroenterology Clinics of NorthAmerica 2001; 30: 547\u2013563.","journal-title":"Gastroenterology Clinics of NorthAmerica"},{"key":"38_CR8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.cger.2007.06.006","volume":"23","author":"O Junaidi","year":"2007","unstructured":"Junaidi O, Di Bisceglie A. Aging liver and hepatitis. Clin Geriatr Med 2007; 23: 889\u2013903.","journal-title":"Clin Geriatr Med"},{"key":"38_CR9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tmaid.2005.10.002","volume":"4","author":"A Genton","year":"2006","unstructured":"Genton A,D\u2019Acremont V, Furrer HJ, Hatz C, Loutan L. Hepatitis A vaccines and the elderly. Travel Medicine and Infectious Disease 2006; 4: 303\u2013312.","journal-title":"Travel Medicine and Infectious Disease"},{"key":"38_CR10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1708-8305.2006.00001.x","volume":"13","author":"V D\u2019Acremont","year":"2006","unstructured":"D\u2019Acremont V, Herzog C, Genton B. Immunogenicity and safety of a virosomal hepatitis. A vaccine (Epaxal) in the elderly. J Travel Med 2006; 13: 78\u201383","journal-title":"J Travel Med"},{"key":"38_CR11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1708-8305.2009.00320.x","volume":"6","author":"L Costas","year":"2009","unstructured":"Costas L, Vilella A, Trilla A, et al. Vaccination Strategies against Hepatitis A in travelers older than 40 years: an economic evaluation. Journal of Travel Medicine 2009; 6: 344\u2013348.","journal-title":"Journal of Travel Medicine"},{"key":"38_CR12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/hep.1840180404","volume":"18","author":"Y Kondo","year":"1993","unstructured":"Kondo Y, Tsukada K, Takeuchi T, et al. High carrier rate after hepatitis B virus infection in the elderly. Hepatology 1993; 18: 768\u201374.","journal-title":"Hepatology"},{"key":"38_CR13","doi-asserted-by":"crossref","unstructured":"EASL Clinical Practice Guidelines: Management of chronic hepatitis B. Journal of Hepatology 2009; 50: 227\u2013242.","DOI":"10.1016\/j.jhep.2008.10.001"},{"key":"38_CR14","first-page":"S3","volume":"39","author":"R Franchis","year":"2003","unstructured":"Franchis R, Hadengue A, Lau GK, et al. EASL international consensus conference on Hepatitis B. J Hepatology 2003; 39: S3\u201325.","journal-title":"J Hepatology"},{"key":"38_CR15","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/hep.20110","volume":"39","author":"AS Lok","year":"2004","unstructured":"Lok AS, McMahon BJ. Chronic hepatitis B. Update of recommendations. Hepatology 2004; 39: 857\u201361.","journal-title":"Hepatology"},{"key":"38_CR16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","volume":"349","author":"T Poynard","year":"1997","unstructured":"Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825\u201332.","journal-title":"Lancet"},{"key":"38_CR17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/hep.510260233","volume":"26","author":"F Roudot-Thoraval","year":"1997","unstructured":"Roudot-Thoraval F, Bastie A, Pawlotsky JM, et al. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6664 patients. Hepatology 1997; 26: 485\u201390.","journal-title":"Hepatology"},{"key":"38_CR18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000213330","volume":"38","author":"A Floreani","year":"1992","unstructured":"Floreani A, Bertin T, Soffiati G, et al. Antihepatitis C virus in the elderly: a seroepidemiological study in a home for the aged. Gerontology 1992; 38: 214\u20136.","journal-title":"Gerontology"},{"key":"38_CR19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1665-2681(19)32152-0","volume":"2","author":"M Torres","year":"2003","unstructured":"TorresMand Poynard T. Risk factors for liver fibrosis progression in patients with chronic hepatitis C. Annals of Hepatology 2003; 2: 5\u201311.","journal-title":"Annals of Hepatology"},{"key":"38_CR20","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/hep.20119","volume":"39","author":"DB Strader","year":"2004","unstructured":"Strader DB,Wright T, Thomas DL, et al. Diagnosis, management , and treatment of hepatitis C. Hepatology 2004; 39:1147\u201371.","journal-title":"Hepatology"},{"key":"38_CR21","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","volume":"358","author":"MP Manns","year":"2001","unstructured":"MannsMP, McHutchison JG, Gordon SC, et al. Peginterferon a-2b plus ribavirin compared with interferon a-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 2001; 358: 958\u201365.","journal-title":"Lancet"},{"key":"38_CR22","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","volume":"347","author":"MW Fried","year":"2002","unstructured":"FriedMW, ShiffmanML, Reddy KR, et al. Peginterferon a-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975\u201382.","journal-title":"N Engl J Med"},{"key":"38_CR23","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1532-5415.1993.tb06184.x","volume":"41","author":"G Bresci","year":"1993","unstructured":"Bresci G, Del Corso L, Romanelli Am, et al. The use of recombinant interferon alfa-2b in elderly patients with anti-HCV-positive chronic active hepatitis. JAm Geriatr Soc, 1993; 41, 857.","journal-title":"JAm Geriatr Soc"},{"key":"38_CR24","first-page":"330","volume":"6","author":"Thiel Van","year":"1995","unstructured":"Van Thiel et al. Treatment of hepatitis C virus in the elderly persons with interferon a. J gerontology, 1995; 6: 330\u2013333.","journal-title":"J gerontology"},{"key":"38_CR25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1440-1746.1995.tb01088.x","volume":"10","author":"N Horiike","year":"1995","unstructured":"Horiike N, Masumoto T, Nakanishi K, et al. Interferon therapy for patients more than 60 years of age with chronic hepatitis C. J Gastroenterol Hepatol 1995; 10: 246\u20139.","journal-title":"J Gastroenterol Hepatol"},{"key":"38_CR26","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00535-004-1448-0","volume":"39","author":"Y Imai","year":"2004","unstructured":"Imai Y, Kasahara A, Tanaka H, et al. Interferon therapy for aged patients with chronic hepatitis C. J Gastroenterol, 2004; 39: 1069\u201377.","journal-title":"J Gastroenterol"},{"key":"38_CR27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-142-2-200501180-00009","volume":"142","author":"Y Shiratori","year":"2005","unstructured":"Shiratori Y, Ito Y, Yokosuka O, et al. Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival. Ann Intern Med, 2005; 142: 105\u201314.","journal-title":"Ann Intern Med"},{"key":"38_CR28","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1572-0241.2006.00556.x","volume":"101","author":"D Thabut","year":"2006","unstructured":"Thabut D, Le Calvez S, Thibault V, et al. Hepatitis C in patients 65 years or older: a severe and neglected curable disease?. AmJ Gastroenterol 2006; 101: 1260\u20137.","journal-title":"AmJ Gastroenterol"},{"key":"38_CR29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1155\/2006\/357259","volume":"20","author":"CG Nudo","year":"2006","unstructured":"Nudo CG,Wong P, Hilzenrat N, et al. Elderly patients are at greater risk of cytopenia during antiviral therapy for hepatitis C. Can J Gastroenterol 2006; 20: 589\u201392.","journal-title":"Can J Gastroenterol"},{"key":"38_CR30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cgh.2008.07.017","volume":"7","author":"A Mindikoglu","year":"2009","unstructured":"Mindikoglu A, Miller R. Hepatitis C in the Elderly: Epidiomology, Natural History, and Treatment. Clinical gastroenterology and hepatoloy 2009; 7: 128\u2013134.","journal-title":"Clinical gastroenterology and hepatoloy"},{"key":"38_CR31","doi-asserted-by":"crossref","unstructured":"Honda T, Katano Y, Shimizu J, et al. Efficacy of peginterferon-alfa-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis C. Liver International 2009.","DOI":"10.1111\/j.1478-3231.2009.02064.x"},{"key":"38_CR32","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.amjmed.2008.09.045","volume":"122","author":"K Ikeda","year":"2009","unstructured":"Ikeda K, Arase Y, Kawamura Y, et al. Necessities of Interferon therapy in Elderly patients with Chronic Hepatitis C. The American Journal of Medicine 2009; 122: 479\u2013486.","journal-title":"The American Journal of Medicine"},{"key":"38_CR33","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1532-5415.2006.00643_4.x","volume":"54","author":"A Floreani","year":"2006","unstructured":"Floreani A, Minola E, Carderi I, et al. Are elderly patients poor candidates for pegylated interferon plus ribavirin in the treatment of chronic hepatitis C? J. Am. Geriatr. Soc 2006; 54: 549\u2013550.","journal-title":"Am. Geriatr. Soc"},{"key":"38_CR34","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2006.04.007","volume":"45","author":"T Al-Chalabi","year":"2006","unstructured":"Al-Chalabi T, Boccato S, Portmann B, McFarlane I, Heneghan M. Autoimmune hepatitis in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. Journal of Hepatology, 2006; 45: 575\u2013583.","journal-title":"Journal of Hepatology"},{"key":"38_CR35","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2036.2005.02403.x","volume":"21","author":"C Verslype","year":"2005","unstructured":"Verslype C, George C, Buchel E, Nevens F, Van SteenbergenW, Fevery J. Diagnosis and treatment of autoimmune hepatitis at age 65 and older. Aliment Pharmacol Ther, 2005; 21: 695\u2013699.","journal-title":"Aliment Pharmacol Ther"},{"key":"38_CR36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/ageing\/23.1.22","volume":"23","author":"D Collier","year":"1994","unstructured":"Collier D, Curless R, Bassendine M, James O. Clinical features and prognosis of hepatocellulair carcinoma in Britain in relation to age. Age and ageing, 1994; 23: 22\u201327.","journal-title":"Age and ageing"},{"key":"38_CR37","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1111\/j.1572-0241.1999.01376.x","volume":"94","author":"R Poon","year":"1999","unstructured":"Poon R, Fan S, Lo C, Liu C, et al. Hepatocellular carcinoma in the elderly: Results of surgical and nonsurgical management. The American Journal of Gastro-enterology, 1999; 94: 2460\u20132466.","journal-title":"The American Journal of Gastro-enterology"},{"key":"38_CR38","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00268-009-0122-3","volume":"33","author":"K Shirabe","year":"2009","unstructured":"Shirabe K, Kajiyama K, Harimoto N, et al. Early outcome following hepatic resection in patients older than 80 years of age. World J Surg, 2009; 33: 1927\u20131932.","journal-title":"World J Surg"},{"key":"38_CR39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1072-7515(00)00778-X","volume":"192","author":"K Hanazaki","year":"2001","unstructured":"Hanazaki K, Kajikawa S, Shimozawa N, et al. Hepatic Resection for Hepatocellular Carcinoma in the Elderly. JAm Coll Surg, 2001; 192: 38\u201346.","journal-title":"JAm Coll Surg"},{"key":"38_CR40","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.3748\/wjg.14.6774","volume":"14","author":"T Kazuto","year":"2008","unstructured":"Kazuto T, Yukihiro S. Practical guidelines for diagnosis and early management of druginduced liver injury. World J Gastroenterol 2008; 14: 6774\u20136785.","journal-title":"World J Gastroenterol"},{"key":"38_CR41","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1136\/gut.2008.163675","volume":"58","author":"S Verma","year":"2009","unstructured":"Verma S, Kaplowitz N. Diagnosis, management and prevention of drug-induced liver injury. Gut 2009; 58: 1555\u20131564.","journal-title":"Gut"},{"key":"38_CR42","doi-asserted-by":"crossref","unstructured":"NorrisW, Angelo H, Lewis J. Drug-induced liver injury in 2007. Curr Opin Gastroenterol 24: 287\u2013297.","DOI":"10.1097\/MOG.0b013e3282f9764b"}],"container-title":["Tijdschrift voor Gerontologie en Geriatrie"],"original-title":[],"language":"nl","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12439-011-0038-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12439-011-0038-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12439-011-0038-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:26:02Z","timestamp":1699363562000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvgg.nl\/article\/view\/17140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1007\/s12439-011-0038-x","relation":{},"ISSN":["0167-9228","1875-6832"],"issn-type":[{"value":"0167-9228","type":"print"},{"value":"1875-6832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}